Browsing by Author Tondini, Carlo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2014Adjuvant exemestane with ovarian suppression in premenopausal breast cancerCoates, Alan; Burstein, Harold J.; Colleoni, Marco; et al, Various; Fleming, G. F.; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Perez, E. A.; Regan, Meredith M.; Tondini, Carlo; Walley, B; School of Public Health: Public HealthAdjuvant exemestane with ovarian suppression in premenopausal breast cancer, New England Journal of Medicine, vol.371, 2, 2014,pp 107-118
2014Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequencesCoates, Alan; Campone, Mario; Debled, M.; DeCensi, Andrea; et al, Various; Guerrieri-Gonzaga, Aliana; McIntosh, Christina; Monnier, Alain; Schönenberger, Astrid; Sun, Zhuoxin; Thurlimann, B.; Tondini, Carlo; School of Public Health: Public HealthBone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences, Breast Cancer Research and Treatment, vol.144, 2, 2014,pp 321-329
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2015Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trialsCoates, Alan; Bernhard, Jurg; Burstein, Harold J.; Colleoni, Marco; et al, Various; Luo, Weixiu; Pinotti, Graziella; Puglisi, Fabio; Ribi, Karin; Ruhstaller, Thomas; Spazzapan, Simon; Tondini, Carlo; School of Public Health: Public HealthPatient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials, The Lancet Oncology, vol.16, 7, 2015,pp 848-858